Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a ...

For many Americans, the weight-loss medications broadly referred to as GLP-1s are transforming the way they think and feel about exercise, and in some cases, reshaping a relationship long defined by ...

While the study involved only 20 participants in a controlled setting, doctors believe the results offer practical guidance. Shifting away from ultra-processed foods and toward whole, minimally ...

Ending treatment with a GLP-1 obesity drug often led to steady weight regain — usually faster than after quitting diet- and exercise-based programs, a new research review found. Health improvements ...

Millions of Americans are turning to GLP-1 weight loss medications like Ozempic and Wegovy. But here’s the question few are ...

A new study has found people who stop using weight-loss injections are likely to regain the weight they have lost in under two years The research, published by the British Medical Journal (BMJ), also ...

Weight loss can change a person's life and boost health, especially after years of struggling with obesity. No wonder losing weight is among the top 2026 New Year’s resolutions for Americans, along ...

The mother of Travis and Jason Kelce clapped back at critics who commented on her appearance in a photo promoting the 'Traitors' finale and reunion special ...